Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000254410 | SCV000317609 | benign | Cardiovascular phenotype | 2015-03-11 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Gene |
RCV000420580 | SCV000524349 | benign | not specified | 2016-09-23 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Labcorp Genetics |
RCV001520754 | SCV001729935 | benign | Primary dilated cardiomyopathy | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV002244725 | SCV002514831 | benign | Glucocorticoid deficiency 5 | 2021-12-05 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV004712231 | SCV005275338 | benign | not provided | criteria provided, single submitter | not provided |